激活蛋白和RNA聚合酶II转录装置之间的新型中介体
R J Kelleher1, P M Flanagan, R D Kornberg
1Department of Cell Biology, Fairchild Center, Stanford University School of Medicine, California 94305.
Cell
|June 29, 1990
概括
基因激活蛋白可以干扰真核细胞中彼此的功能. 一种新的酵母因子逆转了这种干扰,表明它调解了转录激活.
科学领域:
- 分子生物学分子生物学
- 基因规则 基因规则
- 单核细胞转录 单核细胞转录
背景情况:
- 基因激活蛋白通过与DNA结合和招募转录机制来调节基因表达.
- 不同基因激活剂之间的干扰可能发生,影响细胞过程.
- 了解这些相互作用对于破译基因调节机制至关重要.
研究的目的:
- 为了研究在真核细胞中激活器干扰的现象.
- 为了确定参与调节基因激活蛋白相互作用的因素.
- 阐明调制激活器干扰的机制.
主要方法:
- 构建和测试混合酵母-疹基因激活蛋白.
- 试管体内转录试验用于研究激活剂干扰.
- 酵母成分的生物化学净化,可以逆转干扰.
主要成果:
- 一种混合基因激活蛋白被证明可以抑制酵母中的特定DNA元素的转录激活.
- 这种激活器干扰在体外实验中是可重现的.
- 一个部分净化的酵母成分,与RNA聚合酶II和其他转录因子不同,逆转了干扰.
结论:
- 激活器干扰是真核生物基因调节中的一个可证明的生物过程.
- 一种新的酵母因子在调节激活器干扰方面发挥着作用.
- 这种新型因素可能会调解转录激活过程,突出显示出一种新的调节机制.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
siRNA - Small Interfering RNAs
18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
Small interfering RNAs (siRNA)
4.3K
No description available
4.3K
Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Hepatic Drug Excretion: Influencing Factors
539
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
539